Skip to main content

Advertisement

Log in

Anti-agalactosyl IgG antibody in ankylosing spondylitis and psoriatic arthritis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Anti-agalactosyl IgG antibody (anti-Gal(0) IgG) has been regarded as a useful serological marker for rheumatoid arthritis (RA). It is unknown whether it is also elevated in serum and implicated in the pathogenesis of joint inflammation in seronegative spondyloarthropathy (SpA) such as ankylosing spondylitis (AS) and psoriatic arthritis (PsA). Sera were collected from 43 patients with AS or PsA with axial joint involvement, 22 patients with RA, and 25 healthy normal individuals for the detection of anti-Gal(0) IgG with a cup-type lectin enzyme immunoassay (Eitest CA.RF). The disease activity of the AS/PsA was evaluated by Bath Ankylosing Spondylitis Disease Activity Score (BASDAI), the serum C-reactive protein (CRP) and IgA were measured by nephelometry, and erythrocyte sedimentation rate (ESR) was measured by Westergren’s method. The median titers of anti-Gal(0) IgG were significantly elevated in patients with RA (167.85, 15.73∼797.58 AU/mL) and AS/PsA (186.15, 34.71∼651.19 AU/mL), compared to those of the normal controls (13.04, 12.00∼202.43 AU/mL). The titers of the anti-Gal(0) IgG in patients with AS/PsA were correlated to the BASDAI scores (r 2 = 0.422, SEE = 1.443, p < 0.001) and serum CRP (r 2 = 0.345, SEE = 2.434, p < 0.001) but not to IgA (r 2 = 0.0259, SEE = 126.30, p < 0.001) or ESR (r 2 = 0.171, SEE = 31.053, p = 0.0059). Collectively, the anti-Gal(0) IgG is elevated and vaguely correlated with the disease activity of AS/PsA although its titers in these patients were erratic. The result of the present investigation has suggested that anti-Gal(0) IgG may be more ubiquitously present in inflammatory arthritides including RA or SpA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, and the European Spondylarthropathy Study Group et al (1991) The European spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34:1218–1227

    Article  CAS  PubMed  Google Scholar 

  2. Zochling J, Brandt J, Braun J (2005) The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis. Rheumatology 44:1483–1491

    Article  CAS  PubMed  Google Scholar 

  3. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324

    Article  CAS  PubMed  Google Scholar 

  4. Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F (1992) The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 35:498–502

    Article  CAS  PubMed  Google Scholar 

  5. Parekh RB, Dwek RA, Sutton BJ, Fernandes DL, Leung A, Stanworth D, Rademacher TW, Mizuochi T, Taniguchi T, Matsuta K et al (1985) Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 316:452–457

    Article  CAS  PubMed  Google Scholar 

  6. Watson M, Rudd PM, Bland M, Dwek RA, Axford JS (1999) Sugar printing rheumatic diseases: a potential method for disease differentiation using immunoglobulin G oligosaccharides. Arthritis Rheum 42:1682–1690

    Article  CAS  PubMed  Google Scholar 

  7. Kondo S, Mashima T, Kai M, Yamada Y, Yoshizawa M, Hosoda T (1997) The study of serum antiagalactosyl IgG antibody in early rheumatoid arthritis. Rinshou to Kenkyu 72:190–194 (in Japanese)

    Google Scholar 

  8. Ichikawa Y, Yamada C, Horiki T, Hoshina Y, Uchiyama M, Yamada Y, Toumatu J (1998) Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren’s syndrome and rheumatoid arthritis. Clin Exp Rheumatol 16:709–715

    CAS  PubMed  Google Scholar 

  9. Nishijima C, Sato S, Takehara K (2001) Anti-agalactosyl IgG antibodies in sera from patients with systemic sclerosis. J Rheumatol 28:1847–1851

    CAS  PubMed  Google Scholar 

  10. Das H, Atsumi T, Fukushima Y, Shibuya H, Ito K, Yamada Y, Amasaki Y, Ichikawa K, Amengual O, Koike T (2004) Diagnostic value of antiagalactosyl IgG antibodies in rheumatoid arthritis. Clin Rheumatol 23:218–222

    Article  PubMed  Google Scholar 

  11. Goei The HS, Steven MM, van der Linden SM, Cats A (1985) Evaluation of diagnostic criteria for ankylosing spondylitis: a comparison of the Rome, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis. Br J Rheumatol 24:242–249

    Article  Google Scholar 

  12. Jasin HE (1985) Autoantibody specificities of immune complexes sequestered in articular cartilage of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum 28:241–248

    Article  CAS  PubMed  Google Scholar 

  13. Brandtzaeg P (1997) Review article: homing of mucosal immune cells: a possible connection between intestinal and articular inflammation. Aliment Pharmacol Ther 11(Suppl 3):24–37, discussion:37-9

    PubMed  Google Scholar 

  14. Hertzman SKM, Escobar MR A, Littman BH (1987) Correlation of immunoglobulin and C reactive protein levels in ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis 46:273–276

    Article  PubMed  Google Scholar 

  15. van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 27:361–368

    Article  PubMed  Google Scholar 

  16. Veale D, Rogers S, FitzGerald O (1994) Classification of clinical subsets in psoriatic arthritis. Br J Rheumatol 33:133–138

    Article  CAS  PubMed  Google Scholar 

  17. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol 21:2286–2291

    CAS  PubMed  Google Scholar 

  18. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, Jenkinson T (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index. J Rheumatol 21:2281–2285

    CAS  PubMed  Google Scholar 

  19. Prevoo ML, vant Hof MA, van Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48

    Article  CAS  PubMed  Google Scholar 

  20. Yamada Y, Hosoda T, Yosizawa M, Yamane S (1997) Development and evaluation of the lectin-enzyme immunoassay kit for detection of antiagalactosyl IgG antibodies. Kiso To Rinso 31:81–101 (in Japanese)

    CAS  Google Scholar 

  21. van Zeben D, Rook GA, Hazes JM, Zwinderman AH, Zhang Y, Ghelani S, Rademacher TW, Breedveld FC (1994) Early agalactosylation of IgG is associated with a more progressive disease course in patients with rheumatoid arthritis: results of a follow-up study. Br J Rheumatol 33:36–43

    Article  PubMed  Google Scholar 

  22. Young A, Sumar N, Bodman K, Goval S, Sinclair H, Roitt I, Isenberg D (1991) Agalactosyl IgG: an aid to differential diagnosis in early synovitis. Arthritis Rheum 34:1425–1429

    Article  CAS  PubMed  Google Scholar 

  23. Hayashi N, Kumagai S (2003) New diagnostic tests for rheumatoid arthritis. Jap J Clin Pathol 51:1030–1035

    CAS  Google Scholar 

  24. Ohgiya A, Kitajima I (2005) Diagnostic tests: anti-agalactosyl IgG antibody. Nippon Rinsho 63(Suppl 7):469–471 (in Japanese)

    PubMed  Google Scholar 

  25. Tomana M, Schrohenloher RE, Koopman WJ, Alarcón GS, Paul WA (1988) Abnormal glycosylation of serum IgG from patients with chronic inflammatory diseases. Arthritis Rheum 31:333–338

    Article  CAS  PubMed  Google Scholar 

  26. Parekh RB, Roitt IM, Isenberg DA, Dwek RA, Ansell BM, Rademacher TW (1988) Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity. Lancet 1(8592):966–969

    Article  CAS  PubMed  Google Scholar 

  27. Youinou P, Pennec YL, Casburn-Budd R, Dueymes M, Letoux G, Lamour A (1992) Galactose terminating oligosaccharides of IgG in patients with primary Sjögren’s syndrome. J Autoimmun 5:393–400

    Article  CAS  PubMed  Google Scholar 

  28. Bond A, Alavi A, Axford JS, Youinou P, Hay FC (1996) The relationship between exposed galactose and N-acetylglucosamine residues on IgG in rheumatoid arthritis (RA), juvenile chronic arthritis (JCA) and Sjögren’s syndrome (SS). Clin Exp Immunol 105:99–103

    Article  CAS  PubMed  Google Scholar 

  29. Maeno N, Takei S, Fujikawa S, Yamada Y, Imanaka H, Hokonohara M, Kawano Y, Oda H (2004) Antiagalactosyl IgG antibodies in juvenile idiopathic arthritis, juvenile onset Sjögren's syndrome, and healthy children. J Rheumatol 31:1211–1217

    CAS  PubMed  Google Scholar 

  30. Morita Y, Muro Y, Sugiura K, Tomita Y (2008) Anti-cyclic citrullinated peptide antibody in systemic sclerosis. Clin Exp Rheumatol 26:542–547

    CAS  PubMed  Google Scholar 

  31. Matsumoto A, Shikata K, Takeuchi F, Kojima N, Mizuochi T (2000) Autoaantibody activity of IgG rheumatoid factor increases with decreasing levels of galactosylation and sialylation. J Biochem 128:621–628

    CAS  PubMed  Google Scholar 

  32. Vossenaar ER, Smeets TJ, Kraan MC, Raats JM, van Venrooij WJ, Tak PP (2004) The presence of citrullinated proteins is not specific for rheumatoid synovial tissue. Arthritis Rheum 50:3485–3494

    Article  CAS  PubMed  Google Scholar 

  33. Matsui T, Shimada K, Tohma S (2006) Anti-cyclic citrullinated peptide antibody in rheumatic diseases other than rheumatoid arthritis. Clin Rheumatol 25:610–611

    Article  PubMed  Google Scholar 

  34. Demaine AG, Panayi GS, Vaughan RW, Armstrong RD, Welsh KI (1984) Immunoglobulin allotypes in psoriasis, psoriatic arthropathy and ankylosing spondylitis. Exp Clin Immunogenetics 1:61–65

    CAS  Google Scholar 

  35. Cunnane G, Bresnihan B, FitzGerald O (1998) Immunohistologic analysis of peripheral joint disease in ankylosing spondylitis. Arthritis Rheum 41:180–182

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by the grant from National Science Council (NSC 97-2314-B-075-109MY-3) and Taipei Veterans General Hospital (VGH96-C05), Taiwan

Disclosures

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chang-Youh Tsai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chou, CL., Wu, MJ., Yu, CL. et al. Anti-agalactosyl IgG antibody in ankylosing spondylitis and psoriatic arthritis. Clin Rheumatol 29, 875–881 (2010). https://doi.org/10.1007/s10067-010-1413-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-010-1413-7

Keywords

Navigation